A set of molecules found in certain plants appears to have a beneficial effect in brain tissue associated with Alzheimer’s disease, according to a new study conducted in mice. The study was led by researchers at the University of South Florida and Cedars-Sinai Medical Center. An article in the Journal of Cellular and Molecular Medicine is available online.
Terrence Town, Ph.D., one of the senior authors of the study, is available to provide more information about this study. He is a research scientist with the departments of Neurosurgery and Biomedical Sciences at Cedars-Sinai Medical Center, and with the hospital’s neurosurgical research center, the Maxine Dunitz Neurosurgical Institute.
Researchers administered molecules called flavonoids, which are found in certain fruits and vegetables, to a mouse model genetically programmed to develop Alzheimer’s disease. Using two of these molecules, luteolin and diosmin, they were able to reduce the levels of a protein called amyloid-beta, which forms the sticky deposits that build up in the brains of patients with Alzheimer’s. The researchers also determined that these molecules work by targeting a protein called presenilin-1, which has long been linked to Alzheimer’s as a genetic cause of this devastating and untreatable illness.
The results may offer a new approach to therapy for patients suffering from this neurodegenerative illness, which is the most common cause of dementia and is estimated to affect more than five million people in the United States.
“These flavonoids are widely available in natural foods and it appears that they may be used in purified form as therapeutic agents. The compounds have few if any side effects and are naturally occurring in citrus fruits. They also can be found as dietary supplements in health food stores,” Town said.
Source: Cedars-Sinai Medical Center
Related stories:
Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer’s disease, Huntington’s disease, epilepsy, stroke, dementia and malignant gliomas.
Pin1 is beneficial in Alzheimer's disease, detrimental to some forms of dementia
The most common form of dementia, Alzheimer’s disease, and a relatively rare hereditary form of dementia, frontotemporal dementia with parkinsonism-17, share a common pathology: Both are the result of an overaccumulation of tau proteins, which form tangled lesions in the brain’s neurons and eventually lead to the collapse of the brain cells responsible for memory. And, although mutations in the gene encoding tau have not been found in individuals with Alzheimer’s disease, they have been identified in individual with frontotemporal dementia, and are often used as models for studying Alzheimer’s disease.
Umbilical cord blood cell therapy may reduce signs and symptoms of Alzheimer's disease
Targeted immune suppression using human umbilical cord blood cells may improve the pathology associated with Alzheimer’s disease, a new study in a mouse model of this currently untreatable neurodegenerative condition reports. The study, led by researchers at the University of South Florida, is published online in the peer-reviewed journal
Stem Cells and Development.
Umbilical cord blood cell therapy in an animal model of Alzheimer's disease
A novel strategy based on targeted immune suppression using human umbilical cord blood cells may improve the pathology and cognitive decline associated with Alzheimer’s disease, based on the results of a study in a mouse model of this currently untreatable neurodegenerative condition, as described in a groundbreaking report in
Stem Cells and Development.
Worm defecation holds clues to widespread cell-to-cell communication process
The focus of two recent Nobel prizes, a species of roundworm has made possible another advance in the understanding of how cells talk to one another, according to a study published online Feb. 21 in the journal
Current Biology.
It’s All About Geometry: Protein Contact Surfaces Hold Key to Cures
Your mother always told you to do your geometry homework, and for scientists seeking new treatments for diseases like Parkinson’s and Alzheimer’s, this advice turns out to be right on the mark.
Researchers map signaling networks that control neuron function
In the first large-scale proteomics study of its kind, researchers at the University of California, San Diego School of Medicine have mapped thousands of neuronal proteins to discover how they connect into complex signaling networks that guide neuron function. Their research – using quantitative mass spectrometry, computational software and bioinformatics to match the proteins to their cellular functions – may lead to a better understanding of brain development, neurodegenerative diseases, and spinal cord regeneration.
Controversial theory of Alzheimer's origin funded
Dr. Shaohua Xu, Florida Tech associate professor of biological sciences, has an original theory of the origin of Alzheimer’s Disease and has earned a $150,000 grant from Space Florida to test it. The grant was matched with $30,000 from NASA’s Aerospace Medicine and Occupational Health Branch.